Premium
The importance of surgical therapy with expansion of TAVR to low‐risk patients
Author(s) -
Quimby Donald L.,
Brown Garrett,
Belli Erol V.,
Mohanty Bibhu D.
Publication year - 2019
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.14282
Subject(s) - medicine , valvular heart disease , bicuspid aortic valve , valve replacement , ascending aorta , cardiology , regurgitation (circulation) , gold standard (test) , intensive care medicine , surgery , aortic valve , aorta , stenosis
Abstract Despite the landmark release of recent transcatheter aortic valve replacement data, the gold standard of surgical therapy is here to stay. Surgery remains vital in patient populations with low coronary height raising risk of coronary occlusion, aneurysmal ascending aorta, isolated aortic regurgitation, noncalcific disease, bicuspid valves, and multivessel coronary disease, or other structural abnormality requiring cardiac surgery. Consideration of these issues highlights the ongoing importance of multidisciplinary consideration of individual patient cases, careful review of imaging, and preservation of a robust surgical program to complement transcatheter development. As the landscape of valvular heart disease management continues to evolve, the surgeon's role is changing, but by no means diminished and their engagement in heart team decision making remains paramount.